SALK INSTITUTE FOR BIOLOGICAL STUDIES: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- SALK INSTITUTE FOR BIOLOGICAL STUDIES (EIN 95-2160097)
- Tax period
- 2022-07-01 to 2023-06-30
- Filed
- 2024-05-09
- IRS object ID
- 202441309349302309
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-05-09T11:33:11+00:00 | ReturnTs |
| Tax Period End | 2023-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 346565596 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST & YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 101 E WASHINGTON ST | AddressLine1Txt |
| City | PHOENIX | CityNm |
| State Abbreviation | AZ | StateAbbreviationCd |
| ZIP | 85004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 952160097 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | The Salk Institute for Biological Studies | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | SALK | BusinessNameControlTxt |
| Phone | 8584534100 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10010 N TORREY PINES ROAD | AddressLine1Txt |
| City | LA JOLLA | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 920371002 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KIMBERLY M CASTILLO | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 8584534100 | PhoneNum |
| Signature | 2024-05-09 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | KIMBERLY | PersonFirstNm |
| Person Last | CASTILLO | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (true) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Steven T Rutti | PreparerPersonNm |
| PTIN | P00775456 | PTIN |
| Phone | 6023223000 | PhoneNum |
| Preparation | 2023-05-15 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
Principal Ofcr Business Name PrincipalOfcrBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GERALD JOYCE | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10010 N TORREY PINES ROAD | AddressLine1Txt |
| City | LA JOLLA | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 920371002 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $332,858,462 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.SALK.EDU | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1960 | FormationYr |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Activity Or Mission | BASIC RESEARCH IN THE FOLLOWING: MOLECULAR BIOLOGY & GENETICS, NEUROSCIENCE, AND PLANT BIOLOGY. | ActivityOrMissionDesc |
| Voting Members Governing Body | 31 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 25 | VotingMembersIndependentCnt |
| Total Employee | 1144 | TotalEmployeeCnt |
| Total Volunteers | 26 | TotalVolunteersCnt |
| Total Gross UBI | -$1,837,670 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $98,392 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $138,719,997 | PYContributionsGrantsAmt |
| CY Contributions Grants | $150,813,576 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $18,520,658 | PYInvestmentIncomeAmt |
| CY Investment Income | $21,763,570 | CYInvestmentIncomeAmt |
| PY Other Revenue | $5,093,785 | PYOtherRevenueAmt |
| CY Other Revenue | $1,075,216 | CYOtherRevenueAmt |
| PY Total Revenue | $162,334,440 | PYTotalRevenueAmt |
| CY Total Revenue | $173,652,362 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $88,780,643 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $91,143,114 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $5,846,746 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $72,611,028 | PYOtherExpensesAmt |
| CY Other Expenses | $76,263,720 | CYOtherExpensesAmt |
| PY Total Expenses | $161,391,671 | PYTotalExpensesAmt |
| CY Total Expenses | $167,406,834 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $942,769 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $6,245,528 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $759,827,038 | TotalAssetsBOYAmt |
| Total Assets EOY | $805,255,578 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $144,378,095 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $172,966,503 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $615,448,943 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $632,289,075 | NetAssetsOrFundBalancesEOYAmt |
| Mission | INVOLVED IN RESEARCH ACTIVITIES, THE OBJECTIVES OF WHICH ARE THE ADVANCEMENT AND DISSEMINATION OF KNOWLEDGE RELEVANT TO THE HEALTH AND WELLBEING OF HUMANKIND. THE OBJECTIVES ARE MET PRIMARILY THROUGH RESEARCH AND ADVANCED INSTRUCTION IN (A) BIOLOGY, (B) THE CAUSE, PREVENTION AND CURE OF DISEASES, AND (C) THE FACTORS AND CIRCUMSTANCES CONDUCIVE TO THE FULFILLMENT OF HUMANKIND'S BIOLOGICAL POTENTIAL. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $138,470,686 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | SEE SCHEDULE O | Desc |
| Total Program Service Expenses | $138,470,686 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 179 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 1144 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 31 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 25 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | false | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KIMBERLY CASTILLO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 8584534100 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10010 N TORREY PINES ROAD | AddressLine1Txt |
| City | LA JOLLA | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 920371002 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (42 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|
| FRED GAGE PHD | |||||||
| PRESIDENT (OUTGOING APRIL 2023)/PROFESSOR | 50.0 | Yes (X) | Yes (X) | $884,422 | $0 | $53,918 | |
| GERALD JOYCE MD PHD | |||||||
| PRESIDENT (INCOMING APRIL 2023)/PROFESSOR | 50.0 | Yes (X) | Yes (X) | $451,511 | $0 | $51,587 | |
| MARNA C WHITTINGTON PHD | |||||||
| CHAIR | 2.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| RICHARD A HEYMAN PHD | |||||||
| VICE CHAIR | 2.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| ALAN D GOLD | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| BENJAMIN H LEWIS | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| CAROL GALLAHER PHARMD | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| CORINNE MENTZELOPOULOS | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| DANIEL C LEWIS | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| DANIEL TIERNEY | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| DAVID DOLBY | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| DENNIS DRIVER | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| DONALD L COHN | |||||||
| TRUSTEE (OUTGOING AUGUST 2022) | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| EDWIN K HUNTER | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| ERIC SAGERMAN | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| FREDERICK J DOTZLER | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| FREDERIK PAULSEN PHD | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| HAEYOUNG KONG TANG PHD | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| HOWARD H NEWMAN PHD | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| IRVING WEISSMAN MD | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| IRWIN M JACOBS SM SCD | |||||||
| CHAIR EMERITUS | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| JAY FLATLEY | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| LARRY E JENNINGS | |||||||
| TRUSTEE (OUTGOING AUGUST 2022) | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| LYN HUTTON | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| MARK KNICKREHM | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| MARKUS REINHARD | |||||||
| VICE CHAIR | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| MARTYN GOULDING PHD | |||||||
| TRUSTEE/PROFESSOR | 50.0 | Yes (X) | $266,191 | $0 | $47,114 | ||
| MARY JANE SALK | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| REUBEN SHAW PHD | |||||||
| TRUSTEE/PROFESSOR | 50.0 | Yes (X) | $414,745 | $0 | $48,741 | ||
| SANJAY K JHA PHD | |||||||
| TRUSTEE | 0.5 | Yes (X) | $0 | $0 | $0 | ||
| TATYANA SHARPEE PHD | |||||||
| TRUSTEE/PROFESSOR | 50.0 | Yes (X) | $255,675 | $0 | $41,957 | ||
| TERRY ROSEN PHD | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| TIMOTHY M SCHOEN | |||||||
| TRUSTEE | 2.0 | Yes (X) | $0 | $0 | $0 | ||
| WOLFGANG BUSCH PHD | |||||||
| TRUSTEE/PROFESSOR | 50.0 | Yes (X) | $306,970 | $0 | $43,076 | ||
| JULIA A MILLER JD | |||||||
| SECRETARY/GENERAL COUNSEL | 50.0 | Yes (X) | $391,828 | $0 | $56,235 | ||
| KIM E WITMER | |||||||
| TREASURER/SVP FINANCE & ADMN | 50.0 | Yes (X) | $483,502 | $0 | $46,561 | ||
| KIMBERLY CASTILLO | |||||||
| CHIEF FINANCIAL OFFICER | 50.0 | Yes (X) | $311,772 | $0 | $51,400 | ||
| DAVID LAWRENCE | |||||||
| EXECUTIVE DIRECTOR, HPI | 50.0 | $361,608 | $0 | $1,095 | Yes (X) | ||
| EDWARD CALLAWAY PHD | |||||||
| PROFESSOR | 50.0 | $354,745 | $0 | $52,713 | Yes (X) | ||
| MARTIN HETZER PHD | |||||||
| CSO (OUTGOING MARCH 2023)/PROFESSOR | 50.0 | $438,679 | $0 | $56,018 | Yes (X) | ||
| RONALD EVANS PHD | |||||||
| PROFESSOR | 50.0 | $427,878 | $0 | $32,096 | Yes (X) | ||
| SAMUEL PFAFF PHD | |||||||
| PROFESSOR | 50.0 | $366,432 | $0 | $55,964 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $5,715,958 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $638,475 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 147 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| EAST END ADVISORS LLC | |||||
| 610 FIFTH AVENUE SUITE 506 | NEW YORK | NY | 10020 | INVESTMENT ADVISOR | $2,736,484 |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | TRNG PROGRAM/SUBCONT | $2,595,091 |
| AO REED & CO | |||||
| 4777 RUFFIN STREET | SAN DIEGO | CA | 92111 | CONSTRUCTION SERVICE | $621,177 |
| ISEC INCORPORATED | |||||
| 6000 GREENWOOD PLAZA BLVD 200 | GREENWOOD VILLAGE | CO | 80111 | CONSTRUCTION SERVICE | $520,000 |
| RUDOLPH & SLETTEN INC | |||||
| 7584 METROPOLITAN DR STE 100 | SAN DIEGO | CA | 92108 | CONSTRUCTION SERVICE | $464,212 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 13 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $0 | FederatedCampaignsAmt |
| Membership Dues | $0 | MembershipDuesAmt |
| Fundraising | $1,034,108 | FundraisingAmt |
| Related Organizations | $0 | RelatedOrganizationsAmt |
| Government Grants | $75,856,260 | GovernmentGrantsAmt |
| All Other Contributions | $73,923,208 | AllOtherContributionsAmt |
| Noncash Contributions | $1,865,829 | NoncashContributionsAmt |
| Total Contributions | $150,813,576 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt | ExclusionExclusionAmt |
|---|---|---|---|
| $0 | $0 | $0 | |
| $0 | $0 | $0 | |
| $0 | $0 | $0 | $0 |
| $0 | $0 | $0 | $0 |
| $0 | $0 | $0 | $0 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,646,388 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | -$1,937,670 | UnrelatedBusinessRevenueAmt |
| Exclusion | $6,584,058 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,075,128 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,075,128 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $175,422,509 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $158,305,327 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $17,117,182 | SecuritiesAmt |
| Other | $0 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $17,117,182 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $17,117,182 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $67,600 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $1,034,108 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $900,773 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$833,173 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | -$833,173 | ExclusionAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt | ExclusionExclusionAmt |
|---|---|---|---|---|---|
| OIL ROYALTIES | 900099 | $1,781 | $0 | $0 | $1,781 |
| IMAGE USE FEE | 900099 | $100,000 | $0 | $100,000 | $0 |
| REVENUE SHARE-HOST VEHICLE CHARGING STAT | 900099 | $1,083 | $0 | $0 | $1,083 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$269,603 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | -$269,603 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | -$166,739 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $173,652,362 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | -$1,837,670 | UnrelatedBusinessRevenueAmt |
| Exclusion | $24,676,456 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,901,445 | TotalAmt |
| Program Services | $1,737,484 | ProgramServicesAmt |
| Management And General | $2,008,286 | ManagementAndGeneralAmt |
| Fundraising | $155,675 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $68,660,300 | TotalAmt |
| Program Services | $57,969,040 | ProgramServicesAmt |
| Management And General | $7,382,225 | ManagementAndGeneralAmt |
| Fundraising | $3,309,035 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,659,041 | TotalAmt |
| Program Services | $3,827,992 | ProgramServicesAmt |
| Management And General | $591,775 | ManagementAndGeneralAmt |
| Fundraising | $239,274 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,978,297 | TotalAmt |
| Program Services | $7,378,128 | ProgramServicesAmt |
| Management And General | $1,140,594 | ManagementAndGeneralAmt |
| Fundraising | $459,575 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,944,031 | TotalAmt |
| Program Services | $4,062,148 | ProgramServicesAmt |
| Management And General | $627,973 | ManagementAndGeneralAmt |
| Fundraising | $253,910 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $245,788 | TotalAmt |
| Program Services | $45,000 | ProgramServicesAmt |
| Management And General | $200,788 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,175,992 | TotalAmt |
| Program Services | $731,698 | ProgramServicesAmt |
| Management And General | $444,294 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $246,005 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $246,005 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,070 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $3,070 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,613,145 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $2,613,145 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,698,854 | TotalAmt |
| Program Services | $13,510,928 | ProgramServicesAmt |
| Management And General | $1,831,826 | ManagementAndGeneralAmt |
| Fundraising | $356,100 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $25,388 | TotalAmt |
| Program Services | $6,739 | ProgramServicesAmt |
| Management And General | $9,958 | ManagementAndGeneralAmt |
| Fundraising | $8,691 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $725,992 | TotalAmt |
| Program Services | $209,809 | ProgramServicesAmt |
| Management And General | $474,323 | ManagementAndGeneralAmt |
| Fundraising | $41,860 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,780,312 | TotalAmt |
| Program Services | $2,610,457 | ProgramServicesAmt |
| Management And General | $869,676 | ManagementAndGeneralAmt |
| Fundraising | $300,179 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,289,896 | TotalAmt |
| Program Services | $7,850,311 | ProgramServicesAmt |
| Management And General | $2,028,486 | ManagementAndGeneralAmt |
| Fundraising | $411,099 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,155,870 | TotalAmt |
| Program Services | $998,825 | ProgramServicesAmt |
| Management And General | $103,481 | ManagementAndGeneralAmt |
| Fundraising | $53,564 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,539,783 | TotalAmt |
| Program Services | $1,094,142 | ProgramServicesAmt |
| Management And General | $326,874 | ManagementAndGeneralAmt |
| Fundraising | $118,767 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $304,349 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $304,349 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $11,692,449 | TotalAmt |
| Program Services | $10,664,887 | ProgramServicesAmt |
| Management And General | $930,913 | ManagementAndGeneralAmt |
| Fundraising | $96,649 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $458,660 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $458,660 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| SCIENTIFIC SUBCONTRACTS | $9,053,187 | $9,053,187 | $0 | $0 |
| RESEARCH SUPPLIES | $16,297,930 | $16,297,930 | $0 | $0 |
| REPAIRS & PARTS | $278,538 | $258,630 | $18,656 | $1,252 |
| UBI TAXES | $1,675 | $0 | $1,675 | $0 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $676,837 | TotalAmt |
| Program Services | $163,351 | ProgramServicesAmt |
| Management And General | $472,370 | ManagementAndGeneralAmt |
| Fundraising | $41,116 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $167,406,834 | TotalAmt |
| Program Services | $138,470,686 | ProgramServicesAmt |
| Management And General | $23,089,402 | ManagementAndGeneralAmt |
| Fundraising | $5,846,746 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,250,882 | BOYAmt |
| EOY | $8,278,560 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $22,475,096 | BOYAmt |
| EOY | $24,496,644 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,741,877 | BOYAmt |
| EOY | $36,602,578 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $718,748 | BOYAmt |
| EOY | $1,159,918 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,160,629 | BOYAmt |
| EOY | $409,357 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,325,002 | BOYAmt |
| EOY | $2,276,567 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,836 | BOYAmt |
| EOY | $23,735 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,279,897 | BOYAmt |
| EOY | $1,339,293 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $292,972,954 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $218,232,880 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $73,224,890 | BOYAmt |
| EOY | $74,740,074 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $80,825,357 | BOYAmt |
| EOY | $145,400,000 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $529,022,668 | BOYAmt |
| EOY | $495,706,221 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,786,156 | BOYAmt |
| EOY | $14,822,631 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $759,827,038 | BOYAmt |
| EOY | $805,255,578 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $42,759,193 | BOYAmt |
| EOY | $41,913,073 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $29,265,728 | BOYAmt |
| EOY | $25,958,026 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $67,387,318 | BOYAmt |
| EOY | $94,236,307 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,965,856 | BOYAmt |
| EOY | $10,859,097 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $144,378,095 | BOYAmt |
| EOY | $172,966,503 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $113,937,864 | BOYAmt |
| EOY | $112,765,719 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $501,511,079 | BOYAmt |
| EOY | $519,523,356 | EOYAmt |
Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $615,448,943 | BOYAmt |
| EOY | $632,289,075 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $759,827,038 | BOYAmt |
| EOY | $805,255,578 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $6,245,528 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $9,915,168 | NetUnrlzdGainsLossesInvstAmt |
| Donated Services And Use Fclts | $0 | DonatedServicesAndUseFcltsAmt |
| Investment Expense | $0 | InvestmentExpenseAmt |
| Prior Period Adjustments | $0 | PriorPeriodAdjustmentsAmt |
| Other Changes In Net Assets | $679,436 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $166,753,206 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $160,545,802 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $176,855,692 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $138,798,417 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $150,881,176 | CurrentTaxYearAmt |
| Total | $793,834,293 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $166,753,206 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $160,545,802 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $176,855,692 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $138,798,417 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $150,881,176 | CurrentTaxYearAmt |
| Total | $793,834,293 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $12,425,761 | SubstantialContributorsTotAmt |
| Public Support Total170 | $781,408,532 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,160,349 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,322,033 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $6,807,160 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $9,621,065 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,721,516 | CurrentTaxYearAmt |
| Total | $32,632,123 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,125 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $3,315 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,945 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,857 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,864 | CurrentTaxYearAmt |
| Total | $18,106 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $826,484,522 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $0 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.9455 | PublicSupportCY170Pct |
| Public Support PY170 | 0.9437 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule A, Part II, Line 10 Other Income | FormAndLineReferenceDesc |
| Explanation | DESCRIPTION - OIL ROYALTIES, COLUMN A - 1545.0, COLUMN B - 1093.0, COLUMN C - 993.0, COLUMN D - 2851.0, COLUMN E - 1781.0, COLUMN F - 8263.0; DESCRIPTION - REVENUE SHARING-HOST VEHICLE CHARGING STATION, COLUMN A - 1278.0, COLUMN B - 1228.0, COLUMN C - 952.0, COLUMN D - 2006.0, COLUMN E - 1083.0, COLUMN F - 6547.0; DESCRIPTION - NET GIFT SHOP SALES, COLUMN A - 2302.0, COLUMN B - 994.0, COLUMN C - 0.0, COLUMN D - 0.0, COLUMN E - 0.0, COLUMN F - 3296.0; | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | false | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | false | DirectContactLegislatorsInd |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $3,070 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $3,070 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITY | FormAndLineReferenceDesc |
| Explanation | PAID MEMBERSHIP DUES TO RESEARCH AND BIOMEDICAL ORGANIZATIONS, A PORTION OF WHICH ARE CONSIDERED LOBBYING. ASSOCIATION OF INDEPENDENT RESEARCH INSTITUTES - $1,500, NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH - $1,200, BIOCOM - $370. | ExplanationTxt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $345,211,760 | BeginningYearBalanceAmt |
| Contributions | $4,585,120 | ContributionsAmt |
| Investment Earnings Or Losses | $17,999,745 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $16,695,002 | OtherExpendituresAmt |
| End Year Balance | $351,101,623 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $375,050,161 | BeginningYearBalanceAmt |
| Contributions | $1,603,261 | ContributionsAmt |
| Investment Earnings Or Losses | -$15,394,543 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $16,047,119 | OtherExpendituresAmt |
| End Year Balance | $345,211,760 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $299,166,085 | BeginningYearBalanceAmt |
| Contributions | $14,926,831 | ContributionsAmt |
| Investment Earnings Or Losses | $74,973,285 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $14,016,040 | OtherExpendituresAmt |
| End Year Balance | $375,050,161 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $286,834,762 | BeginningYearBalanceAmt |
| Contributions | $6,580,341 | ContributionsAmt |
| Investment Earnings Or Losses | $17,530,495 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $11,779,513 | OtherExpendituresAmt |
| End Year Balance | $299,166,085 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $240,056,992 | BeginningYearBalanceAmt |
| Contributions | $42,422,494 | ContributionsAmt |
| Investment Earnings Or Losses | $14,937,417 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $10,582,141 | OtherExpendituresAmt |
| End Year Balance | $286,834,762 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.0311 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.728 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.2409 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,153,930 | OtherCostOrOtherBasisAmt |
| Book Value | $1,153,930 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $64,209,980 | OtherCostOrOtherBasisAmt |
| Depreciation | $54,562,927 | DepreciationAmt |
| Book Value | $9,647,053 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $102,610,267 | OtherCostOrOtherBasisAmt |
| Depreciation | $73,412,189 | DepreciationAmt |
| Book Value | $29,198,078 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $123,700,198 | OtherCostOrOtherBasisAmt |
| Depreciation | $88,973,442 | DepreciationAmt |
| Book Value | $34,726,756 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,298,579 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,284,322 | DepreciationAmt |
| Book Value | $14,257 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $74,740,074 | TotalBookValueLandBuildingsAmt |
Other Securities OtherSecuritiesGrp (3 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| ALTERNATIVE INVESTMENTS | $466,747,759 | F |
| STOCKS NOT-PUBLICLY TRADED <5% | $3,011 | C |
| LIMITED PARTNERSHIP INTEREST | $28,955,451 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $495,706,221 | TotalBookValueSecuritiesAmt |
| Federal Income Tax Liability | $5,143 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| DEFERRED RETIREE MEDICAL OBLIG | $4,174,113 |
| LEASE LIABILITY | $6,679,841 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $10,859,097 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $178,205,447 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $9,915,168 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$3,705,857 | OtherRevenueAmt |
| Revenue Not Reported | $6,209,311 | RevenueNotReportedAmt |
| Revenue Subtotal | $171,996,136 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $2,556,446 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | -$900,220 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $1,656,226 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $173,652,362 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $165,750,610 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $900,773 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $900,773 | ExpensesNotReportedAmt |
| Expenses Subtotal | $164,849,837 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $2,556,446 | InvestmentExpensesNotIncld2Amt |
| Other Expenses Not Included | $551 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $2,556,997 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $167,406,834 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule D, Part XI, Line 2(d) | INVESTMENT RETURN IN EXCESS OF AMOUNT DESIGNATED FOR CURRENT OPERATIONS UNDER SPENDING POLICY ($3,659,268), CHANGE IN VALUE OF DEFERRED GIFTS ($46,590), AND ROUNDING $1. |
| Schedule D, Part XI, Line 4(b) | FUNDRAISING EXPENSES ($900,773) AND ROUNDING $553 |
| Schedule D, Part XII, Line 2(d) | FUNDRAISING EVENTS EXPENSE $900,773 AND ROUNDING $552 |
| Schedule D, Part V, Line 4 Intended uses of endowment funds | ENDOWMENT INCOME INTENDED TO BE USED FOR AND TO SUPPORT RESEARCH, OPERATIONS, AND LECTURESHIP EXPENSES. |
| Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote | INCOME TAXES - THE INSTITUTE HAS NO UNRECOGNIZED TAX BENEFITS AS OF JUNE 30, 2023 AND 2022. |
| Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 | INVESTMENT RETURN IN EXCESS OF AMOUNT DESIGNATED FOR CURRENT OPERATIONS UNDER SPENDING POLICY - -3659268 CHANGE IN VALUE OF DEFERRED GIFTS - -46590 ROUNDING - 1 |
| Schedule D, Part XI, Line 4(b) Other revenues in form 990 not in audited financial statements | FUNDRAISING EXPENSES - -900773 ROUNDING - 553 |
| Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 | FUNDRAISING EXPENSES - 900773 |
| Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements | ROUNDING - 551 |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $172,584 |
| North America (Canada & Mexico only) | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $74,790 |
| Central America and the Caribbean | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $5,937 |
| East Asia and the Pacific | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $50,495 |
| Middle East and North Africa | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $2,984 |
| South America | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $9,101 |
| Russia and Neighboring States | 0 | 0 | Program Services | SCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION. | $1,133 |
| Central America and the Caribbean | 0 | 0 | Investments | $210,145,003 | |
| Europe (Including Iceland and Greenland) | 0 | 0 | Investments | $23,265,027 | |
| Sub-Saharan Africa | 0 | 0 | Investments | $372,470 | |
| North America (Canada & Mexico only) | 0 | 0 | Investments | $1,215,756 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $235,315,280 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $235,315,280 | TotalSpentAmt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | Yes (true) | PassiveForeignInvestmestCoInd |
| Foreign Partnership | Yes (true) | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements | FormAndLineReferenceDesc |
| Explanation | CENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; RUSSIA AND NEIGHBORING STATES-Accrual; SOUTH AMERICA-Accrual; SUB-SAHARAN AFRICA-Accrual | ExplanationTxt |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | CONCERT | Event1Nm |
| Gross Receipts Event1 | $1,101,708 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $1,034,108 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $67,600 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $87,653 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $412,589 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $400,531 | OtherDirectExpensesEvent1Amt |
| Gross Revenue Event2 | $0 | GrossRevenueEvent2Amt |
| Other Events Total | 0 | OtherEventsTotalCnt |
| Gross Revenue Other Events | $0 | GrossRevenueOtherEventsAmt |
| Gross Receipts Total | $1,101,708 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $1,034,108 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $67,600 | GrossRevenueTotalEventsAmt |
| Food And Beverage Total Events | $87,653 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $412,589 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $400,531 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $900,773 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$833,173 | NetIncomeSummaryAmt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FRED GAGE PHD | ||||||||||||||
| PRESIDENT (OUTGOING APRIL 2023)/PROFESSOR | $867,507 | $0 | $0 | $0 | $16,915 | $0 | $36,600 | $0 | $17,318 | $0 | $938,340 | $0 | $0 | $0 |
| GERALD JOYCE MD PHD | ||||||||||||||
| PRESIDENT (INCOMING APRIL 2023)/PROFESSOR | $441,224 | $0 | $0 | $0 | $10,287 | $0 | $36,600 | $0 | $14,987 | $0 | $503,098 | $0 | $0 | $0 |
| REUBEN SHAW PHD | ||||||||||||||
| TRUSTEE/PROFESSOR | $250,741 | $0 | $0 | $0 | $164,004 | $0 | $36,600 | $0 | $12,141 | $0 | $463,486 | $0 | $0 | $0 |
| MARTYN GOULDING PHD | ||||||||||||||
| TRUSTEE/PROFESSOR | $246,178 | $0 | $0 | $0 | $20,013 | $0 | $32,622 | $0 | $14,492 | $0 | $313,305 | $0 | $0 | $0 |
| TATYANA SHARPEE PHD | ||||||||||||||
| TRUSTEE/PROFESSOR | $226,204 | $0 | $0 | $0 | $29,471 | $0 | $29,958 | $0 | $11,999 | $0 | $297,632 | $0 | $0 | $0 |
| WOLFGANG BUSCH PHD | ||||||||||||||
| TRUSTEE/PROFESSOR | $215,033 | $0 | $0 | $0 | $91,937 | $0 | $32,744 | $0 | $10,332 | $0 | $350,046 | $0 | $0 | $0 |
| KIM E WITMER | ||||||||||||||
| TREASURER/SVP FINANCE & ADMN | $466,254 | $0 | $0 | $0 | $17,248 | $0 | $36,600 | $0 | $9,961 | $0 | $530,063 | $0 | $0 | $0 |
| JULIA A MILLER JD | ||||||||||||||
| SECRETARY/GENERAL COUNSEL | $373,036 | $0 | $0 | $0 | $18,792 | $0 | $36,600 | $0 | $19,635 | $0 | $448,063 | $0 | $0 | $0 |
| KIMBERLY CASTILLO | ||||||||||||||
| CHIEF FINANCIAL OFFICER | $302,168 | $0 | $0 | $0 | $9,604 | $0 | $36,600 | $0 | $14,800 | $0 | $363,172 | $0 | $0 | $0 |
| MARTIN HETZER PHD | ||||||||||||||
| CSO (OUTGOING MARCH 2023)/PROFESSOR | $404,256 | $0 | $0 | $0 | $34,423 | $0 | $36,600 | $0 | $19,418 | $0 | $494,697 | $0 | $0 | $0 |
| RONALD EVANS PHD | ||||||||||||||
| PROFESSOR | $392,063 | $0 | $0 | $0 | $35,815 | $0 | $30,500 | $0 | $1,596 | $0 | $459,974 | $0 | $0 | $0 |
| SAMUEL PFAFF PHD | ||||||||||||||
| PROFESSOR | $294,058 | $0 | $0 | $0 | $72,374 | $0 | $36,600 | $0 | $19,364 | $0 | $422,396 | $0 | $0 | $0 |
| DAVID LAWRENCE | ||||||||||||||
| EXECUTIVE DIRECTOR, HPI | $355,385 | $0 | $0 | $0 | $6,223 | $0 | $1,095 | $0 | $0 | $0 | $362,703 | $0 | $0 | $0 |
| EDWARD CALLAWAY PHD | ||||||||||||||
| PROFESSOR | $343,386 | $0 | $0 | $0 | $11,359 | $0 | $36,600 | $0 | $16,113 | $0 | $407,458 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule J, Part I, Line 1a First-class or charter travel | FormAndLineReferenceDesc |
| Explanation | FIRST-CLASS OR CHARTER TRAVEL: FRED GAGE, PRESIDENT/PROFESSOR - $22,315; GERALD JOYCE, PRESIDENT/PROFESSOR - $2,869; KIM WITMER, SVP-FINANCE & ADMINISTRATION - $858; MARTIN HETZER. CSO/PROFESSOR - $394. NOT TAXABLE - ACCOUNTABLE PLAN. | ExplanationTxt |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (3 entries)
| Relationship With OrgRelationshipWithOrgTxt | Loan PurposeLoanPurposeTxt | Loan From OrganizationLoanFromOrganizationInd | Original PrincipalOriginalPrincipalAmt | Balance DueBalanceDueAmt | DefaultDefaultInd | Board Or Committee ApprovalBoardOrCommitteeApprovalInd | Written AgreementWrittenAgreementInd |
|---|---|---|---|---|---|---|---|
| REUBEN SHAW | |||||||
| PROFESSOR | HOME LOAN | Yes (X) | $700,000 | $337,550 | false | Yes (true) | Yes (true) |
| TATYANA SHARPEE | |||||||
| PROFESSOR | HOME LOAN | Yes (X) | $30,140 | $30,140 | false | Yes (true) | Yes (true) |
| WOLFGANG BUSCH | |||||||
| PROFESSOR | HOME LOAN | Yes (X) | $250,000 | $41,667 | false | Yes (true) | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $409,357 | TotalBalanceDueAmt |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 118 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,865,829 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Market value | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule M, Part I Explanations of reporting method for number of contributions | FormAndLineReferenceDesc |
| Explanation | Securities - Publicly traded - THE AMOUNT REPORTED REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (15 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part III, Line 4a continued1 | IMAGING REVEALS HOW LARGE HIV PROTEIN FUNCTIONS TO FORM INFECTIOUS VIRUS - UNDERSTANDING HOW HIV REPLICATES WITHIN CELLS IS KEY FOR DEVELOPING NEW THERAPIES FOR THE NEARLY 40 MILLION PEOPLE LIVING WITH HIV GLOBALLY. A TEAM OF SCIENTISTS FROM THE SALK INSTITUTE AND RUTGERS UNIVERSITY HAVE DETERMINED THE MOLECULAR STRUCTURE OF HIV POL, A PROTEIN THAT PLAYS A KEY ROLE IN THE LATE STAGES OF HIV REPLICATION, OR THE PROCESS THROUGH WHICH THE VIRUS PROPAGATES ITSELF AND SPREADS THROUGH THE BODY. DETERMINING THE MOLECULE'S STRUCTURE HELPS ANSWER LONGSTANDING QUESTIONS ABOUT HOW THE PROTEIN BREAKS ITSELF APART TO ADVANCE THE REPLICATION PROCESS. THE DISCOVERY REVEALS A NEW VULNERABILITY IN THE VIRUS THAT COULD BE TARGETED WITH DRUGS. THE STUDY WAS LED BY ASSISTANT PROFESSOR DMITRY LYUMKIS AND PUBLISHED IN SCIENCE ADVANCES ON JULY 6, 2022. THE BEST OFFENSE IS A GREAT DEFENSE FOR SOME CARNIVOROUS PLANTS - INSECT-EATING PLANTS HAVE FASCINATED BIOLOGISTS FOR MORE THAN A CENTURY, BUT HOW PLANTS EVOLVED THE ABILITY TO CAPTURE AND CONSUME LIVE PREY HAS LARGELY REMAINED A MYSTERY. NOW, SALK SCIENTISTS, ALONG WITH COLLABORATORS FROM WASHINGTON UNIVERSITY IN ST. LOUIS, HAVE INVESTIGATED THE MOLECULAR BASIS OF PLANT CARNIVORY AND FOUND EVIDENCE THAT IT EVOLVED FROM MECHANISMS PLANTS USE TO DEFEND THEMSELVES. THE RESEARCH DETAILS HOW CALCIUM MOLECULES MOVE DYNAMICALLY WITHIN CELLS IN THE LEAVES OF CARNIVOROUS PLANTS IN RESPONSE TO TOUCH FROM LIVE PREY. THE STUDY WAS LED BY PROFESSOR JOANNE CHORY AND PUBLISHED IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES ON JULY 11, 2022. HOW RNA PROCESSING GOES AWRY IN RARE IMMUNE DISEASE - RESEARCHERS AT THE SALK INSTITUTE AND KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (KAUST) IN SAUDI ARABIA DISCOVERED A NEW UNDERLYING CAUSE OF WISKOTT-ALDRICH SYNDROME, A RARE GENETIC DISEASE THAT LEADS TO BLEEDING AND IMMUNE DEFICIENCIES IN BABIES. THEY FOUND THE GENETIC MUTATIONS ASSOCIATED WITH WISKOTT-ALDRICH SYNDROME DISRUPT RNA SPLICING WHICH, IN TURN, PREVENTS NUMEROUS IMMUNE AND ANTI-INFLAMMATORY PROTEINS FROM BEING MADE CORRECTLY. THE STUDY WAS LED BY PROFESSOR JUAN CARLOS IZPISUA BELMONTE AND PUBLISHED IN NATURE COMMUNICATIONS ON JUNE 25, 2022. MAKING A MEMORY POSITIVE OR NEGATIVE - RESEARCHERS AT THE SALK INSTITUTE AND COLLEAGUES DISCOVERED THE MOLECULE IN THE BRAIN RESPONSIBLE FOR ASSOCIATING GOOD OR BAD FEELINGS WITH A MEMORY. THEIR DISCOVERY PAVES THE WAY FOR A BETTER UNDERSTANDING OF WHY SOME PEOPLE ARE MORE LIKELY TO RETAIN NEGATIVE EMOTIONS THAN POSITIVE ONES-AS CAN OCCUR WITH ANXIETY, DEPRESSION OR POST-TRAUMATIC STRESS DISORDER (PTSD). THE STUDY WAS LED BY PROFESSOR KAY TYE AND PUBLISHED IN NATURE ON JULY 20, 2022. A SURPRISING LINK BETWEEN MITOCHONDRIAL DNA AND INCREASED ATHEROSCLEROSIS RISK - MITOCHONDRIA ARE KNOWN AS CELLS' POWERHOUSES, BUT MOUNTING EVIDENCE SUGGESTS THEY ALSO PLAY A ROLE IN INFLAMMATION. SCIENTISTS FROM THE SALK INSTITUTE AND UC SAN DIEGO EXAMINED HUMAN BLOOD CELLS AND DISCOVERED A SURPRISING LINK BETWEEN MITOCHONDRIA, INFLAMMATION AND DNMT3A AND TET2-TWO GENES THAT NORMALLY HELP REGULATE BLOOD CELL GROWTH BUT, WHEN MUTATED, ARE ASSOCIATED WITH AN INCREASED RISK OF ARTERY-BLOCKING PLAQUE BUILDUP KNOWN AS ATHEROSCLEROSIS. THE FINDINGS COULD LEAD TO NEW THERAPEUTICS FOR ATHEROSCLEROSIS AND OTHER INFLAMMATORY DISEASES. THE STUDY WAS LED BY PROFESSOR GERALD SHADEL AND PUBLISHED IN IMMUNITY ON AUGUST 2, 2022. DISCOVERY ADVANCES THE POTENTIAL OF GENE THERAPY TO RESTORE HEARING LOSS - RESEARCH FROM THE SALK INSTITUTE AND THE UNIVERSITY OF SHEFFIELD MAY DRIVE THE DEVELOPMENT OF NEW GENE THERAPIES TO REPAIR HEARING LOSS. IN DEVELOPED COUNTRIES, ROUGHLY 80 PERCENT OF DEAFNESS CASES THAT OCCUR BEFORE A CHILD LEARNS TO SPEAK ARE DUE TO GENETIC FACTORS. ONE OF THESE GENETIC COMPONENTS LEADS TO THE ABSENCE OF THE PROTEIN EPS8, WHICH COINCIDES WITH IMPROPER DEVELOPMENT OF SENSORY HAIR CELLS IN THE INNER EAR. THE TEAM'S FINDINGS SHOW THAT DELIVERY OF NORMAL EPS8 CAN RESCUE STEREOCILIA ELONGATION AND THE FUNCTION OF AUDITORY HAIR CELLS IN THE EARS OF MICE AFFECTED BY THE LOSS OF EPS8. THE STUDY WAS LED BY ASSISTANT PROFESSOR URI MANOR AND PUBLISHED IN MOLECULAR THERAPY - METHODS & CLINICAL DEVELOPMENT ON JULY 31, 2022. NEW TARGET IDENTIFIED FOR TREATMENT OF PREMATURE AGING DISEASE - SCIENTISTS AT THE SALK INSTITUTE AND KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (KAUST) IN SAUDI ARABIA DISCOVERED THAT A STRETCH OF DNA THAT HOPS AROUND THE HUMAN GENOME PLAYS A ROLE IN PREMATURE AGING DISORDERS. IN PEOPLE WITH EARLY AGING, OR PROGERIA, RNA ENCODED BY THIS MOBILE DNA BUILDS UP INSIDE CELLS. THE SCIENTISTS ALSO FOUND THAT BLOCKING THIS RNA REVERSES THE DISEASE IN MICE. THE STUDY WAS LED BY PROFESSOR JUAN CARLOS IZPISUA BELMONTE AND PUBLISHED IN SCIENCE TRANSLATIONAL MEDICINE ON AUGUST 10, 2022. HOW THE BRAIN GATHERS THREAT CUES AND TURNS THEM INTO FEAR - SCIENTISTS AT THE SALK INSTITUTE UNCOVERED A MOLECULAR PATHWAY THAT DISTILLS THREATENING SIGHTS, SOUNDS AND SMELLS INTO A SINGLE MESSAGE: BE AFRAID. A MOLECULE CALLED CGRP ENABLES NEURONS IN TWO SEPARATE AREAS OF THE BRAIN TO BUNDLE THREATENING SENSORY CUES INTO A UNIFIED SIGNAL, TAG IT AS NEGATIVE AND CONVEY IT TO THE AMYGDALA, WHICH TRANSLATES THE SIGNAL INTO FEAR. THE RESEARCH MAY LEAD TO NEW THERAPIES FOR FEAR-RELATED DISORDERS SUCH AS POST-TRAUMATIC STRESS DISORDER (PTSD) OR HYPERSENSITIVITY DISORDERS SUCH AS AUTISM, MIGRAINES AND FIBROMYALGIA. THE STUDY WAS LED BY ASSISTANT PROFESSOR SUNG HAN AND PUBLISHED IN CELL REPORTS ON AUGUST 16, 2022. HOW LIGHT AND TEMPERATURE WORK TOGETHER TO AFFECT PLANT GROWTH - PLANTS LENGTHEN AND BEND TO SECURE ACCESS TO SUNLIGHT. DESPITE OBSERVING THIS PHENOMENON FOR CENTURIES, SCIENTISTS DO NOT FULLY UNDERSTAND IT. SALK SCIENTISTS DISCOVERED THAT TWO PLANT FACTORS-THE PROTEIN PIF7 AND THE GROWTH HORMONE AUXIN-ARE THE TRIGGERS THAT ACCELERATE GROWTH WHEN PLANTS ARE SHADED BY CANOPY AND EXPOSED TO WARM TEMPERATURES AT THE SAME TIME. THE FINDINGS WILL HELP SCIENTISTS INCREASE CROP PRODUCTIVITY DESPITE RISING GLOBAL TEMPERATURES. THE STUDY WAS LED BY PROFESSOR JOANNE CHORY AND PUBLISHED IN NATURE COMMUNICATIONS ON AUGUST 29, 2022. BEYOND NEURONS: HOW CELLS CALLED ASTROCYTES CONTRIBUTE TO BRAIN DISORDERS - MOST RESEARCH ON BRAIN DISEASES FOCUSES ON NEURONS, BUT STAR-SHAPED CELLS CALLED ASTROCYTES, ANOTHER ABUNDANT CELL IN THE HUMAN BRAIN, MAY BEAR THE BRUNT OF THE RESPONSIBILITY IN SOME NEURODEVELOPMENTAL DISORDERS. SALK INSTITUTE SCIENTISTS IDENTIFIED A MOLECULE PRODUCED BY ASTROCYTES THAT INTERFERES WITH NORMAL NEURON DEVELOPMENT IN RETT, FRAGILE X AND DOWN SYNDROMES, AND REPORT THAT BLOCKING THE MOLECULE REDUCES THE SIGNS OF DISEASE IN MICE BRAINS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR NICOLA ALLEN AND PUBLISHED IN NATURE NEUROSCIENCE ON AUGUST 30, 2022. AGGRESSION DE-ESCALATION GENE IDENTIFIED IN FRUIT FLIES - THE BRAIN MECHANISMS THAT CAUSE AGGRESSIVE BEHAVIOR HAVE BEEN WELL STUDIED, BTU FAR LESS IS KNOWN ABOUT THE PROCESSES THAT TELL THE BODY WHEN IT'S TIME TO STOP FIGHTING. SALK INSTITUTE SCIENTISTS IDENTIFIED A GENE AND A GROUP OF CELLS IN THE BRAIN THAT PLAY A CRITICAL ROLE IN SUPPRESSING AGGRESSION IN FRUIT FLIES. THE FINDINGS HAVE IMPLICATIONS FOR DISORDERS SUCH AS PARKINSON'S DISEASE, WHICH CAN SOMETIMES CAUSE BEHAVIORAL CHANGES LIKE INCREASED AGGRESSION AND COMBATIVENESS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR KENTA ASAHINA AND PUBLISHED IN SCIENCE ADVANCES ON SEPTEMBER 7, 2022. TIME-RESTRICTED EATING IMPROVES HEALTH OF FIREFIGHTERS - FIREFIGHTER'S 24-HOUR SHIFTS ARE HARD ON THE BODY AND INCREASE THE RISK OF CARDIOMETABOLIC DISEASES, SUCH AS HEART DISEASE AND DIABETES, AS WELL AS CANCER. IN COLLABORATION WITH THE SAN DIEGO FIRE-RESCUE DEPARTMENT, SCIENTISTS FROM THE SALK INSTITUTE AND UC SAN DIEGO HEALTH CONDUCTED A CLINICAL TRIAL AND FOUND THAT TIME-RESTRICTED EATING IMPROVED MEASURES OF HEALTH AND WELLBEING IN FIREFIGHTERS. THE NEW FINDINGS MAY ALSO HAVE IMPLICATIONS FOR SHIFT WORKERS, SUCH AS MILITARY PERSONNEL; HEALTH CARE, FOOD SERVICE, AND TRANSPORTATION PROFESSIONALS; TELECOMMUNICATIONS STAFF; AND NEW PARENTS, WHOSE SCHEDULES OFTEN MIMIC SHIFT WORK WHEN CARING FOR A NEW BABY. THE STUDY WAS LED BY PROFESSOR SATCHIDANANDA PANDA AND PUBLISHED IN CELL METABOLISM ON OCTOBER 4, 2022. |
| Form 990, Part III, Line 4a continued2 | GROWING MOTOR NEURONS GUIDED BY "LOVE-HATE RELATIONSHIP" WITH BLOOD VESSELS - WHEN NEURONS INVOLVED IN MOVEMENT-CALLED MOTOR NEURONS-FORM, THEY MUST BUILD CONNECTIONS THAT REACH FROM THE BRAIN, BRAINSTEM, OR SPINAL CORD ALL THE WAY TO THE HEAD, ARMS, OR THE TIPS OF THE TOES. A COLLABORATIVE STUDY BETWEEN SALK INSTITUTE SCIENTISTS AND COLLEAGUES AT THE SAN RAFFAELE SCIENTIFIC INSTITUTE IN ITALY SHOWED HOW BLOOD VESSEL GENES PLAY A CRITICAL ROLE IN MOTOR NEURON DEVELOPMENT BY TELLING BLOOD VESSELS TO GET OUT OF THE WAY. THE DISCOVERY HAS IMPLICATIONS FOR UNDERSTANDING DISEASES IN WHICH MOTOR NEURON CONNECTIONS ARE DESTROYED, SUCH AS AMYOTROPHIC LATERAL SCLEROSIS (ALS) OR SPINAL MUSCULAR ATROPHY (SMA). THE STUDY WAS LED BY PROFESSOR SAMUEL PFAFF AND PUBLISHED IN NEURON ON OCTOBER 7, 2022. ANTI-INFLAMMATORY MOLECULES DECLINE IN THE AGING BRAIN - AGING INVOLVES INFLAMMATION, STRESS, METABOLISM CHANGES, AND MORE. A TEAM OF SALK INSTITUTE AND UC SAN DIEGO SCIENTISTS REVEALED ANOTHER FACTOR IMPLICATED IN THE AGING PROCESS-A CLASS OF LIPIDS CALLED SGDGS (3-SULFOGALACTOSYL DIACYLGLYCEROLS) THAT DECLINE IN THE BRAIN WITH AGE AND MAY HAVE ANTI-INFLAMMATORY EFFECTS. THE RESEARCH HELPS UNRAVEL THE MOLECULAR BASIS OF BRAIN AGING, REVEALS NEW MECHANISMS UNDERLYING AGE-RELATED NEUROLOGICAL DISEASES, AND OFFERS FUTURE OPPORTUNITIES FOR THERAPEUTIC INTERVENTION. THE STUDY WAS LED BY PROFESSOR ALAN SAGHATELIAN AND PUBLISHED IN NATURE CHEMICAL BIOLOGY ON OCTOBER 20, 2022. DETERIORATING NEURONS ARE SOURCE OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE - SCIENTISTS FROM THE SALK INSTITUTE FOUND THAT NEURONS FROM PEOPLE WITH ALZHEIMER'S DISEASE SHOW DETERIORATION AND UNDERGO A LATE-LIFE STRESS PROCESS CALLED SENESCENCE. THESE NEURONS HAVE A LOSS OF FUNCTIONAL ACTIVITY, IMPAIRED METABOLISM, AND INCREASED BRAIN INFLAMMATION. THE RESEARCHERS ALSO DISCOVERED THAT TARGETING THE DETERIORATING NEURONS WITH THERAPEUTICS COULD BE AN EFFECTIVE STRATEGY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE. THE STUDY WAS LED BY PROFESSOR RUSTY GAGE AND PUBLISHED IN CELL STEM CELL ON DECEMBER 1, 2022. FLIPPING THE SWITCH: GENETIC CHANGES THAT TURN "ON" CANCER GENES - CANCER CAN BE CAUSED BY GENETIC MUTATIONS, YET THE IMPACT OF SPECIFIC TYPES SUCH AS STRUCTURAL VARIANTS THAT BREAK AND REJOIN DNA, CAN VARY WIDELY. RESEARCHERS FROM THE SALK INSTITUTE ZEROED IN ON SPECIFIC MECHANISMS THAT ACTIVATE ONCOGENES, SHOWING THAT THE ACTIVITY OF CANCER-ASSOCIATED MUTATIONS DEPENDS ON THE DISTANCE BETWEEN A PARTICULAR GENE AND THE SEQUENCES THAT REGULATE THE GENE, AS WELL AS ON THE LEVEL OF ACTIVITY OF THE REGULATORY SEQUENCES INVOLVED. THIS WORK ADVANCES THE ABILITY TO PREDICT AND INTERPRET WHICH GENETIC MUTATIONS FOUND IN CANCER GENOMES ARE CAUSING THE DISEASE. THE STUDY WAS LED BY ASSISTANT PROFESSOR JESSE DIXON AND PUBLISHED IN NATURE ON DECEMBER 7, 2022. NEW COMPOUND REVERSES GUT INFLAMMATION IN MICE - A DRUG DEVELOPED BY SALK INSTITUTE RESEARCHERS ACTS LIKE A MASTER RESET SWITCH IN THE INTESTINES. THE COMPOUND, CALLED FEXD, HAS PREVIOUSLY BEEN FOUND TO LOWER CHOLESTEROL, BURN FAT, AND WARD OFF COLORECTAL CANCER IN MICE. NOW, THE TEAM REPORTED THAT FEXD CAN ALSO PREVENT AND REVERSE INTESTINAL INFLAMMATION IN MOUSE MODELS OF INFLAMMATORY BOWEL DISEASE. THE STUDY WAS LED BY PROFESSOR RONALD EVANS AND PUBLISHED IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES ON DECEMBER 12, 2022. THE BRAIN'S ABILITY TO PERCEIVE SPACE EXPANDS LIKE THE UNIVERSE - SALK SCIENTISTS DISCOVERED THAT TIME SPENT EXPLORING AN ENVIRONMENT CAUSES NEURAL REPRESENTATIONS TO GROW IN SURPRISING WAYS. THEIR FINDINGS SHOW THAT NEURONS IN THE HIPPOCAMPUS ESSENTIAL FOR SPATIAL NAVIGATION, MEMORY, AND PLANNING REPRESENT SPACE IN A MANNER THAT CONFORMS TO A NONLINEAR HYPERBOLIC GEOMETRY-A THREE-DIMENSIONAL EXPANSE THAT GROWS OUTWARD EXPONENTIALLY. IN OTHER WORDS, IT'S SHAPED LIKE THE INTERIOR OF AN EXPANDING HOURGLASS. THE RESEARCHERS ALSO FOUND THAT THE SIZE OF THAT SPACE GROWS WITH TIME SPENT IN A PLACE. THIS DISCOVERY PROVIDES VALUABLE METHODS FOR ANALYZING DATA ON NEUROCOGNITIVE DISORDERS INVOLVING LEARNING AND MEMORY, SUCH AS ALZHEIMER'S DISEASE. THE STUDY WAS LED BY PROFESSOR TATYANA SHARPEE AND PUBLISHED IN NATURE NEUROSCIENCE ON DECEMBER 29, 2022. MICROPROTEIN INCREASES APPETITE IN MICE - OBESITY AND METABOLIC DISEASES, SUCH AS DIABETES, ARE EXTREMELY COMMON IN THE UNITED STATES. TINY PROTEINS CALLED MICROPROTEINS HAVE LONG BEEN OVERLOOKED IN RESEARCH, BUT NEW EVIDENCE DEMONSTRATES THAT THEY HAVE AN IMPORTANT ROLE IN METABOLISM. SALK INSTITUTE SCIENTISTS DISCOVERED THAT BOTH BROWN AND WHITE FAT IS FILLED WITH THOUSANDS OF PREVIOUSLY UNKNOWN MICROPROTEINS, AND SHOWED THAT ONE OF THESE MICROPROTEINS, CALLED GM8773, CAN INCREASE APPETITE IN MICE. THESE FINDINGS COULD LEAD TO THE DEVELOPMENT OF A THERAPEUTIC TO HELP PEOPLE GAIN WEIGHT IN CERTAIN DISEASE SITUATIONS, SUCH AS DURING CHEMOTHERAPY FOR CANCER. THE STUDY WAS LED BY PROFESSOR ALAN SAGHATELIAN AND PUBLISHED IN CELL METABOLISM ON JANUARY 3, 2023. TIME-RESTRICTED EATING RESHAPES GENE EXPRESSION THROUGHOUT THE BODY - EXACTLY HOW TIME-RESTRICTED FEEDING AFFECTS THE BODY ON THE MOLECULAR LEVEL, AND HOW THOSE CHANGES INTERACT ACROSS MULTIPLE ORGAN SYSTEMS, HAS NOT BEEN WELL UNDERSTOOD. SCIENTISTS AT THE SALK INSTITUTE SHOWED HOW TIME-RESTRICTED EATING INFLUENCES GENE EXPRESSION IN MICE ACROSS MORE THAN 22 REGIONS OF THE BODY AND BRAIN. THE FINDINGS HAVE IMPLICATIONS FOR A WIDE RANGE OF HEALTH CONDITIONS WHERE TIME-RESTRICTED EATING HAS SHOWN POTENTIAL BENEFITS, INCLUDING DIABETES, HEART DISEASE, HYPERTENSION, AND CANCER. THE STUDY WAS LED BY PROFESSOR SATCHIDANANDA PANDA AND PUBLISHED IN CELL METABOLISM ON JANUARY 3, 2023. SUPPLEMENTATION WITH AMINO ACID SERINE EASES NEUROPATHY IN DIABETIC MICE - APPROXIMATELY HALF OF PEOPLE WITH TYPE 1 OR TYPE 2 DIABETES EXPERIENCE PERIPHERAL NEUROPATHY-WEAKNESS, NUMBNESS, AND PAIN, PRIMARILY IN THE HANDS AND FEET. SALK INSTITUTE RESEARCHERS IDENTIFIED A NEW FACTOR CONTRIBUTING TO DIABETES-ASSOCIATED PERIPHERAL NEUROPATHY: ALTERED AMINO ACID METABOLISM. THE TEAM FOUND THAT DIABETIC MICE WITH LOW LEVELS OF TWO RELATED AMINO ACIDS, SERINE AND GLYCINE, ARE AT HIGHER RISK FOR PERIPHERAL NEUROPATHY. THEY WERE ALSO ABLE TO ALLEVIATE NEUROPATHY SYMPTOMS IN DIABETIC MICE BY SUPPLEMENTING THEIR DIETS WITH SERINE. THE STUDY WAS LED BY PROFESSOR CHRISTIAN METALLO AND PUBLISHED IN NATURE ON JANUARY 25, 2023. TELOMERES, MITOCHONDRIA, AND INFLAMMATION WORK TOGETHER TO PREVENT CANCER - A TEAM OF SALK SCIENTISTS DISCOVERED THAT WHEN TELOMERES, THE END CAPS OF OUR CHROMOSOMES, BECOME VERY SHORT, THEY COMMUNICATE WITH MITOCHONDRIA, THE CELL'S POWERHOUSES. THIS COMMUNICATION TRIGGERS A COMPLEX SET OF SIGNALING PATHWAYS AND INITIATES AN INFLAMMATORY RESPONSE THAT DESTROYS CELLS THAT COULD OTHERWISE BECOME CANCEROUS. THE FINDINGS OPEN NEW POSSIBILITIES FOR PREVENTING AND TREATING CANCER AND OTHER HARMFUL CONSEQUENCES OF AGING. THE STUDY WAS LED BY PROFESSORS JAN KARLSEDER AND GERALD SHADEL AND PUBLISHED IN NATURE ON FEBRUARY 8, 2023. AI CHATBOT CHATGPT MIRRORS ITS USERS TO APPEAR INTELLIGENT - THE ARTIFICIAL INTELLIGENCE (AI) LANGUAGE MODEL CHATGPT MAY HAVE MANY APPLICATIONS IN SCIENCE AND BUSINESS, BUT HOW MUCH DO THESE TOOLS UNDERSTAND WHAT WE SAY TO THEM AND HOW DO THEY DECIDE WHAT TO SAY BACK? SALK INSTITUTE SCIENTISTS EXPLORED THE RELATIONSHIP BETWEEN THE HUMAN INTERVIEWER AND LANGUAGE MODELS TO UNCOVER WHY CHATBOTS RESPOND IN PARTICULAR WAYS, WHY THOSE RESPONSES VARY, AND HOW TO IMPROVE THEM IN THE FUTURE. THE RESULTS SUGGEST THAT LANGUAGE MODELS REFLECT THE INTELLIGENCE AND DIVERSITY OF THEIR INTERVIEWER. THE STUDY WAS LED BY PROFESSOR TERRENCE SEJNOWSKI AND PUBLISHED IN NEURAL COMPUTATION ON FEBRUARY 17, 2023. NEW COMBINATION OF DRUGS WORKS TOGETHER TO REDUCE LUNG TUMORS IN MICE - STANDARD CHEMOTHERAPY AND IMMUNOTHERAPY TREATMENTS ARE NOT EFFECTIVE AGAINST NON-SMALL CELL LUNG CANCERS (NSCLCS) THAT HAVE AN LKB1 GENETIC MUTATION. A NEW STUDY REVEALED FDA-APPROVED TRAMETINIB AND ENTINOSTAT (WHICH IS CURRENTLY IN CLINICAL TRIALS) CAN BE GIVEN IN TANDEM TO PRODUCE FEWER AND SMALLER TUMORS IN MICE WITH LKB1-MUTATED NSCLC. THE STUDY WAS LED BY PROFESSOR REUBEN SHAW AND PUBLISHED IN SCIENCE ADVANCES ON MARCH 17, 2023. |
| Form 990, Part III, Line 4a continued3 | WEARABLE MICROSCOPES ADVANCE SPINAL CORD IMAGING IN MICE - WHILE THE SPINAL CORD IS KNOWN TO PLAY AN ESSENTIAL ROLE IN RELAYING PAIN SIGNALS, TECHNOLOGY HAS LIMITED SCIENTISTS' UNDERSTANDING OF HOW THIS PROCESS OCCURS ON A CELLULAR LEVEL. SALK SCIENTISTS CREATED WEARABLE MICROSCOPES TO ENABLE UNPRECEDENTED INSIGHT INTO THE SIGNALING PATTERNS THAT OCCUR WITHIN THE SPINAL CORDS OF MICE. THESE TECHNOLOGICAL ADVANCEMENTS WILL HELP RESEARCHERS BETTER UNDERSTAND THE NEURAL BASIS OF SENSATIONS AND MOVEMENT IN HEALTHY AND DISEASE CONTEXTS, SUCH AS CHRONIC PAIN, ITCH, AMYOTROPHIC LATERAL SCLEROSIS (ALS), OR MULTIPLE SCLEROSIS (MS). THE STUDIES WERE LED BY ASSOCIATE PROFESSOR AXEL NIMMERJAHN AND PUBLISHED IN NATURE COMMUNICATIONS ON MARCH 21, 2023, AND NATURE BIOTECHNOLOGY ON MARCH 6, 2023. NOT ALL ITCHES ARE THE SAME, ACCORDING TO THE BRAIN - RESEARCH BY SALK INSTITUTE SCIENTISTS REVEALED A DEDICATED BRAIN PATHWAY THAT DRIVES THE MECHANICAL SENSATION OF ITCH (E.G., THE SENSATION OF A MOSQUITO CRAWLING ON YOUR ARM) AND IS DISTINCT FROM THE NEURAL PATHWAY THAT ENCODES THE CHEMICAL SENSATION OF ITCH (E.G., FROM THE MOSQUITO'S SALIVA AFTER A BITE). THEY FOUND THAT A SMALL POPULATION OF NEURONS RELAYS MECHANICAL ITCH INFORMATION FROM THE SPINAL CORD TO THE BRAIN AND ALSO IDENTIFIED THE NEUROPEPTIDE SIGNALS THAT REGULATE BOTH ITCH TYPES. THE FINDINGS OPEN NEW AVENUES FOR THERAPEUTIC INTERVENTIONS FOR CHRONIC ITCH CONDITIONS, INCLUDING ATOPIC DERMATITIS AND PSORIASIS. THE STUDY WAS LED BY PROFESSOR MARTYN GOULDING AND ASSISTANT PROFESSOR SUNG HAN, AND PUBLISHED IN NEURON ON APRIL 5, 2023. MITOCHONDRIA POWER-SUPPLY FAILURE MAY CAUSE AGE-RELATED COGNITIVE IMPAIRMENT - RESEARCHERS AT THE SALK INSTITUTE FOUND THAT THE LOSS OF SYNAPSES BETWEEN NEURONS OCCURS WITH BOTH HEALTHY AND MEMORY-IMPAIRED AGING, BUT WHAT DIFFERS IS THE BREAKDOWN IN THE STANDARD CORRELATION BETWEEN THE SIZES OF SYNAPTIC BOUTONS AND THE MITOCHONDRIA INSIDE. THE FINDINGS HIGHLIGHT THIS VIOLATION OF THE ULTRASTRUCTURAL SIZE PRINCIPLE AND MITOCHONDRIA-RELATED FAILURES AS THE KEY TO AGE-RELATED COGNITIVE IMPAIRMENT, USHERING IN A NEW ERA FOR AGING RESEARCH. THE STUDY WAS LED BY PROFESSOR JOHN REYNOLDS AND PUBLISHED IN FRONTIERS IN AGING NEUROSCIENCE ON APRIL 12, 2023. CRACKING THE CASE OF MITOCHONDRIAL REPAIR AND REPLACEMENT IN METABOLIC STRESS - WHEN CELLULAR ENERGY LEVELS DIP, THE CELL RESPONSE TO THIS METABOLIC STRESS IS TO GET RID OF THE DAMAGED MITOCHONDRIA AND CREATE NEW ONES-BUT HOW THIS OCCURS REMAINED UNCLEAR. SCIENTISTS AT THE SALK INSTITUTE FOUND THAT A PROTEIN CALLED FNIP1 IS THE CRITICAL LINK BETWEEN A CELL SENSING LOW ENERGY LEVELS AND ELIMINATING AND REPLACING DAMAGED MITOCHONDRIA. THIS FUNDAMENTAL DISCOVERY CAN HELP US UNDERSTAND HEALTHY AGING, CANCEROUS TUMORS, NEURODEGENERATIVE DISEASES, AND MORE. THE STUDY WAS LED BY PROFESSOR REUBEN SHAW AND PUBLISHED IN SCIENCE ON APRIL 20, 2023. HOW AN AGGRESSION-PROMOTING BRAIN PEPTIDE WORKS IN FRUIT FLIES - SALK RESEARCHERS SHOWED HOW NEUROPEPTIDES RELEASED FROM A SMALL GROUP OF NEURONS CAN RESHAPE ACTIVITY PATTERNS IN MULTIPLE DOWNSTREAM BRAIN AREAS IN THE FLY AND IMPACT THE ANIMAL'S BEHAVIOR. THE FINDINGS ARE AN IMPORTANT STEP TO UNDERSTANDING HOW VARIABLE RESPONSES TO NEUROPEPTIDES CONTRIBUTE TO HUMAN CONDITIONS LIKE AUTISM-SPECTRUM DISORDER OR ATTENTION-DEFICIT DISORDERS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR KENTA ASAHINA AND PUBLISHED IN THE JOURNAL OF NEUROSCIENCE ON MAY 10, 2023. A NEW MODEL OF STUDYING HUMAN BRAIN IMMUNE CELLS AND NEUROLOGICAL DISORDERS - UNLIKE SOME HUMAN CELLS THAT CAN BE STUDIED OUTSIDE OF THE BODY OR IN NONHUMAN MODELS, HUMAN MICROGLIA ARE DIFFICULT TO STUDY WHEN REMOVED FROM THE HUMAN-BRAIN-LIKE ENVIRONMENT. TO OVERCOME THIS BARRIER, SALK SCIENTISTS DEVELOPED AN ORGANOID MODEL THAT ALLOWS RESEARCHERS TO STUDY HUMAN MICROGLIAL DEVELOPMENT AND FUNCTION FOR THE FIRST TIME IN LIVING HUMAN-DERIVED TISSUE. THE SCIENTISTS ALSO EXAMINED PATIENT-DERIVED MICROGLIA FROM CHILDREN WITH MACROCEPHALIC AUTISM SPECTRUM DISORDER, HIGHLIGHTING THE IMPORTANCE OF IMMUNE CELL AND BRAIN INTERACTIONS IN NEURODEGENERATIVE AND DEVELOPMENTAL DISEASES. THE STUDY WAS LED BY PROFESSOR RUSTY GAGE AND PUBLISHED IN CELL ON MAY 11, 2023. SEEING THE INSIDES OF PLANTS IN 3D - SALK SCIENTISTS DEVELOPED A NEW TECHNOLOGY THAT CAN CAPTURE THE INTERNAL PLANT WORLD AT AN UNPRECEDENTED RESOLUTION, OPENING THE DOOR FOR UNDERSTANDING HOW PLANTS RESPOND TO A CHANGING CLIMATE. THE METHOD, CALLED PHYTOMAP, CAN CAPTURE ENTIRE PLANT TISSUES (LIKE THE WHOLE ROOT TIP), INSTEAD OF A SMALL SLICE, AND PROVIDES INSIGHT INTO THE COMPLEX BIOLOGICAL CONVERSATIONS BETWEEN CELLS THAT IS DIFFICULT IN TWO DIMENSIONS. THE STUDY WAS LED BY PROFESSOR JOSEPH ECKER AND PUBLISHED IN NATURE PLANTS ON JUNE 12, 2023. MAPPING THE DEVELOPMENT OF INFECTION-FIGHTING IMMUNE CELLS - SPECIALIZED IMMUNE CELLS, CALLED CYTOTOXIC T CELLS, CAN DEVELOP INTO SHORT-LIVED EFFECTOR CELLS THAT KILL INFECTED OR CANCEROUS CELLS WITHIN OUR BODIES. A SMALL PORTION OF THOSE EFFECTOR CELLS REMAIN AFTER AN INFECTION AND BECOME LONGER-LIVED MEMORY CELLS. SALK SCIENTISTS DISCOVERED THAT A PROTEIN COMPLEX CALLED CBAF CAN OPEN OR CLOSE GENETIC "DOORS" TO CONTROL WHETHER A T CELL BECOMES AN EFFECTOR OR A MEMORY CELL. THE FINDINGS ILLUMINATE HOW T CELLS FIGHT AND REMEMBER INFECTIONS AND PAVE THE WAY FOR THE DEVELOPMENT OF MORE EFFECTIVE VACCINES AND CANCER THERAPEUTICS. THE STUDY WAS LED BY PROFESSOR SUSAN KAECH AND ASSOCIATE PROFESSOR DIANA HARGREAVES, AND PUBLISHED IN IMMUNITY ON JUNE 13, 2023. ALL THE IMMUNITY, NONE OF THE SYMPTOMS - SALK SCIENTISTS DISCOVERED THAT, IN MICE, PAIRING DISEASE-CAUSING BACTERIA WITH SPECIFIC DIETARY INTERVENTIONS CREATES LONG-TERM IMMUNITY, REVEALING A NEW POTENTIAL VACCINATION STRATEGY FOR DIARRHEAL DISEASES LIKE E. COLI. THE STUDY WAS LED BY PROFESSOR JANELLE AYRES AND PUBLISHED IN SCIENCE ADVANCES ON JUNE 23, 2023. |
| Form 990, Part VI, Line 1a Delegate broad authority to a committee | THE EXECUTIVE COMMITTEE SHALL ADVISE AND AID THE OFFICERS OF THE CORPORATION IN ALL MATTERS CONCERNING ITS INTERESTS, INCLUDING WITHOUT LIMITATION ALL MATTERS RELATING TO COMPENSATION AND BENEFITS, AND SHALL POSSESS AND MAY EXERCISE, DURING THE INTERVALS BETWEEN THE MEETINGS OF THE BOARD OF TRUSTEES, ALL THE POWERS AND AUTHORITY OF THE BOARD OF TRUSTEES IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE CORPORATION, INCLUDING THE POWER TO AUTHORIZE THE CORPORATE SEAL TO BE AFFIXED TO ANY AND ALL DOCUMENTS WHICH MAY REQUIRE THE SAME TO BE AFFIXED THERETO, INSOFAR AS SUCH SEEMS TO THE EXECUTIVE COMMITTEE FOR THE BEST INTERESTS OF THE CORPORATION, IN ALL CASES IN WHICH SPECIFIC DIRECTIONS SHALL NOT HAVE BEEN GIVEN BY THE BOARD OF TRUSTEES, EXCEPT THAT THE EXECUTIVE COMMITTEE SHALL HAVE NO POWER TO ADOPT, AMEND, OR REPEAL THE BY-LAWS. |
| Form 990, Part VI, Line 6 Classes of members or stockholders | MEMBERSHIP OF THE CORPORATION CONSISTS OF THE PERSONS ELECTED TO THE BOARD OF TRUSTEES AND THREE MEMBERS FROM AMONG THE RESIDENT AND NON-RESIDENT FELLOWS AND PROFESSORS CHOSEN AND ELECTED ANNUALLY BY THE RESIDENT AND NON-RESIDENT FELLOWS AND PROFESSORS. |
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | THE MEMBERS OF THE CORPORATION ELECT THE TRUSTEES. |
| Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders | THE MEMBERS OF THE CORPORATION MAY ALTER, AMEND, OR REPEAL THE BY-LAWS BY VOTE. |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE FORM 990 IS PREPARED BY THE INSTITUTE, INTERNALLY REVIEWED BY THE CHIEF FINANCIAL OFFICER AND EXTERNALLY REVIEWED BY THE TAX DEPARTMENT OF A PUBLIC ACCOUNTING FIRM. PRIOR TO ELECTRONIC FILING, A COPY OF THIS FORM 990 IS PROVIDED TO AND DISCUSSED IN THE EXECUTIVE SESSION OF THE BOARD OF TRUSTEES. |
| Form 990, Part VI, Line 12c Conflict of interest policy | ANNUALLY, THE CONFLICT OF INTEREST DISCLOSURE STATEMENT IS SENT OUT FOR COMPLETION BY THE MEMBERS OF THE BOARD OF TRUSTEES, SENIOR MEMBERS OF ADMINISTRATION AND RESEARCHERS. THE DESIGNATED OFFICIAL FOR EACH GROUP REVIEWS THE COMPLETED FORMS AND BRINGS ANY POTENTIAL CONFLICT OF INTEREST TO THE RESPECTIVE COMMITTEES FOR REVIEW. UPON DETERMINATION THAT A CONFLICT OF INTEREST EXISTS, THE FOLLOWING CONDITIONS OR RESTRICTIONS MAY BE IMPOSED: A. MONITORING OF ACTIVITIES GENERATING THE CONFLICT BY ANOTHER MEMBER; B. DISQUALIFICATION FROM PARTICIPATION IN THE ACTIVITIES GIVING RISE TO THE CONFLICT; C. MODIFICATION OF RESPONSIBILITIES TO AVOID CONFLICTS; D. PUBLIC DISCLOSURE OR DIVESTITURE OF SIGNIFICANT FINANCIAL INTERESTS; E. MODIFICATION OF THE RESEARCH PLAN OR REMOVAL OF THE AFFECTED RESEARCHER FROM THE RESEARCH; F. SEVERANCE OF RELATIONSHIP THAT CREATES ACTUAL OR POTENTIAL CONFLICTS; G. TERMINATION OF EMPLOYMENT. |
| Form 990, Part VI, Line 15a Process to establish compensation of top management official | A COMPREHENSIVE MARKET ASSESSMENT WAS COMPLETED IN APRIL 2023 BASED ON DATA FROM A SELECTED PEER GROUP AND HISTORICAL OVERALL MARKET DATA FOR SALK PRESIDENT AND EXECUTIVE LEADERSHIP ROLES. THIS REPORT WAS PROVIDED TO THE CHAIR AND CO-CHAIRS OF SALK'S BOARD OF TRUSTEES AND TO SALK'S CURRENT PRESIDENT AND PREVIOUS PRESIDENT. SALK'S PRESIDENT FOR THE PERIOD THROUGH APRIL 2023 DISCUSSED THE PERFORMANCE OF EACH VICE-PRESIDENT LEVEL EXECUTIVE AT A SPECIAL MEETING HELD ON JUNE 13, 2023, WITH THE CHAIR AND CO-CHAIR OF THE BOARD OF DIRECTORS AND SALK'S CURRENT PRESIDENT. AFTER DISCUSSION, RECOMMENDED CHANGES WERE APPROVED FOR VICE-PRESIDENT LEVEL INCUMBENTS ON SALK'S EXECUTIVE LEADERSHIP TEAM. NO CHANGES WERE RECOMMENDED FOR THE SALK PRESIDENT ROLE DUE TO THE LIMITED TENURE OF THE INCUMBENT. ALL COMPENSATION CHANGES WERE EFFECTIVE JULY 1, 2023. |
| Form 990, Part VI, Line 15b Process to establish compensation of other employees | A COMPREHENSIVE MARKET ASSESSMENT WAS COMPLETED IN APRIL 2023 BASED ON DATA FROM A SELECTED PEER GROUP AND HISTORICAL OVERALL MARKET DATA FOR SALK PRESIDENT AND EXECUTIVE LEADERSHIP ROLES. THIS REPORT WAS PROVIDED TO THE CHAIR AND CO-CHAIRS OF SALK'S BOARD OF TRUSTEES AND TO SALK'S CURRENT PRESIDENT AND PREVIOUS PRESIDENT. SALK'S PRESIDENT FOR THE PERIOD THROUGH APRIL 2023 DISCUSSED THE PERFORMANCE OF EACH VICE-PRESIDENT LEVEL EXECUTIVE AT A SPECIAL MEETING HELD ON JUNE 13, 2023, WITH THE CHAIR AND CO-CHAIR OF THE BOARD OF DIRECTORS AND SALK'S CURRENT PRESIDENT. AFTER DISCUSSION, RECOMMENDED CHANGES WERE APPROVED FOR VICE-PRESIDENT LEVEL INCUMBENTS ON SALK'S EXECUTIVE LEADERSHIP TEAM. NO CHANGES WERE RECOMMENDED FOR THE SALK PRESIDENT ROLE DUE TO THE LIMITED TENURE OF THE INCUMBENT. ALL COMPENSATION CHANGES WERE EFFECTIVE JULY 1, 2023. |
| Form 990, Part VI, Line 19 Required documents available to the public | UPON REQUEST, THE OFFICE OF THE CHIEF FINANCIAL OFFICER MAKES AVAILABLE TO THE PUBLIC THE INSTITUTE'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY. FINANCIAL STATEMENTS ARE AVAILABLE ON THE SALK WEBSITE. |
| Form 990, Part VII, Section A DIRECTORS COMPENSATION | THE FOLLOWING INDIVIDUALS WERE COMPENSATED FOR THE FOLLOWING SERVICES AND NOT PAID AS TRUSTEES: FRED GAGE, PH.D. - PRESIDENT/PROFESSOR; REUBEN SHAW, PH.D. - PROFESSOR; MARTYN GOULDING, PH.D. - PROFESSOR; TATYANA SHARPEE, PH.D. - PROFESSOR. |
| Form 990, Part VIII, Line 11d Other Miscellaneous Revenue | A/R RECHARGE ALLOWANCE - Total Revenue: -269603, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: -269603; |
| Form 990, Part XI, Line 9 Other changes in net assets or fund balances | POSTRETIREMENT BENEFIT CHANGES OTHER THAN NET PERIODIC BENEFIT COST - 726028; CHANGE IN VALUE OF DEFERRED GIFTS - -46590; ROUNDING - -2; |
Schedule R IRS990ScheduleR
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Entity TypeEntityTypeTxt | Share Of Total IncomeShareOfTotalIncomeAmt | Share Of EOY AssetsShareOfEOYAssetsAmt | OwnershipOwnershipPct | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SALK INSTITUTE COMMERCIAL SERVICES CORP | ||||||||||||
| 10010 N TORREY PINES ROAD | LA JOLLA | CA | 920371002 | 232159172 | MGMT SERVICES | PA | SALK INSTITUTE | C Corporation | $4 | $41,138 | 1.0000 | Yes (true) |
| CHARITABLE REMAINDER TRUSTS (5) | ||||||||||||
| SUPPORT | CA | NA | Trust | |||||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Comments